SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States
- PMID: 34425451
- PMCID: PMC8255188
- DOI: 10.1016/j.diagmicrobio.2021.115468
SARS-CoV-2 N gene mutations impact detection by clinical molecular diagnostics: reports in two cities in the United States
Abstract
Nasal and nasopharyngeal swab specimens tested by the Cepheid Xpert Xpress SARS-CoV-2 were analyzed by whole-genome sequencing based on impaired detection of the N2 target. Each viral genome had at least one mutation in the N gene, which likely arose independently in the New York City and Pittsburgh study sites.
Keywords: COVID-19; Cepheid XpertXpress; SARS-CoV-2; SARS-CoV-2 diagnostic testing; single nucleotide polymorphisms.
Copyright © 2021. Published by Elsevier Inc.
Figures
References
-
- Artesi M, Bontems S, Gobbels P, Franckh M, Maes P, Boreux R, et al. A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay. J Clin Microbiol. 2020;58:e01598–20. - PMC - PubMed
-
- Farr B, Rajan D, Betteridge E, Shirley L, Quail M, Park N, et al. protocols.io; 2020. COVID-19 ARTIC v3 illumina library construction and sequencing protocol V.5. Available at: dx.doi.org/10.17504/protocols.io.bibtkann. Accessed January 28, 2020.
-
- Centers for Disease Control . U.S. Department of Health and Human Services; 2020. 2019-nCoV Real-time rRT-PCR panel primers and probes.https://www.cdc.gov/coronavirus/2019-ncov/downloads/rt-pcr-panel-primer-... Available at: Accessed January 29, 2021.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
